Abstract
Atropine sulfate is the sulfate salt of atropine, which is an alkaloid found in its natural form together with scopolamine and hyoscyamine in the plant Atropa belladonna. The first synthesis of atropine was achieved by Richard Willstätter, a German organic chemist whose studies in the field of alkaloids brought him the 1915 Nobel Prize for Chemistry. Usual doses of atropine (>0.5 mg) abolish various types of vagal reflexmediated bradycardia or asystole and also prevent or abolish the negative chronotropic effect produced by other parasympathomimetic drugs. Atropine also ameliorates the AV conduction when an incomplete block is noted. In some patients with complete heart block, the resultant escape rhythm rate (junctional origin) may be accelerated by atropine.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Schweitzer P, Mark H. The effect of atropine on cardiac arrhythmias and conduction. Part 1. Am Heart J. 1980;100:255–61.
Robinson GC, Draper G. Rhythmic changes in the human heart. Heart. 1912;4:97–106.
Wilson FN. The production of atrioventricular rhythm in man after the administration of atropine. Arch Intern Med. 1915;16:989–98.
Thomas M, Woodgate D. The effect of atropine on bradycardia and hypotension in acute myocardial infarction. Br Heart J. 1966;28:409–13.
Harris A, Bluest R. Treatment of slow heart rate following acute myocardial infarction. Br Heart J. 1966;28:631–7.
Adgey AAJ, Geddes JA, Mulholland HC, Keegan DAJ, Pantridge JF. Incidence, significance and management of early bradyarrhythmias complicating acute myocardial infarction. Lancet. 1968;23:1097–101.
Shillingford J, Thomas M. Treatment of bradycardia and hypotension syndrome in patients with acute myocardial infarction. Am Heart J. 1968;75:843–4.
Harvey RD, Belevych AE. Muscarinic regulation of cardiac ion channels. Br J Pharmacol. 2003;139:1074–84.
Montano N, Cogliati C, Porta A, Pagani M, Malliani A, Narkiewicz K, et al. Central vagotonic effects of atropine modulate spectral oscillations of sympathetic nerve activity. Circulation. 1998;98:1394–9.
Hinderling PH, Gundert-Remy U, Schmidlin O, Heinzel G. Integrated pharmacokinetics and pharmacodynamics of atropine in healthy humans. II: pharmacodynamics. J Pharm Sci. 1985;74:711–7.
Adams RG, Verma P, Jackson AJ, Miller RL. Plasma pharmacokinetics of intravenously administered atropine in normal human subjects. J Clin Pharmacol. 1982;22:477–81.
Van der Meer MJ, Hundt HK, Müller FO. The metabolism of atropine in man. J Pharm Pharmacol. 1986;38:781–4.
Kahn G. Cardiac drug therapy. 7th ed. Totowa: Humana Press; 2007. p. 198.
Josephson ME. Sinus node function. In: Josephson ME, editor. Clinical cardiac electrophysiology. Philadelphia: Wolters Kluwer/Lippincott Williams &Wilkins; 2008. p. 71.
Craig FN. Effects of atropine, work and heat on heart rate and sweat production in man. J Appl Physiol. 1952;4:826–33.
Mandel WJ, Hayakawa H, Allen HN, Danzig R, Kermaier AI. Assessment of sinus node function in patients with the sick sinus syndrome. Circulation. 1972;46:761–9.
Mandel WJ, Laks MM, Obayashi K. Sinus node function; evaluation in patients with and without sinus node disease. Arch Intern Med. 1975;135:388–94.
Morton HJV, Thomas ET. Effect of atropine on heart rate. Lancet. 1958;2:1313.
Reiffel JA, Bigger JT, Giardina EG. “Paradoxical” prolongation of sinus nodal recovery time after atropine in the sick sinus syndrome. Am J Cardiol. 1975;36:98–104.
Dhingra RC, Amat-Y-Leon F, Wyndham C, Denes P, Wu D, Miller RH, et al. Electrophysiologic effects of atropine on sinus node and atrium in patients with sinus nodal dysfunction. Am J Cardiol. 1976;38:848–55.
Opthof T. The normal range and determinants of the intrinsic heart rate in man. Cardiovasc Res. 2000;1(45):173–6.
Sethi KK, Balachandar J, Jaishankar S, Gupta MP. Differential effects of autonomic blockade on sinus and supraventricular tachycardia and dual atrioventricular atrioventricular nodal function in normals and in intrinsic sinus node dysfunction. Int J Cardiol. 1986;12:233–42.
Bissett JK, de Soyza ND, Kane JJ, Murphy ML. Electrophysiology of atropine. Cardiovasc Res. 1975;9:73–80.
Neuss H, Schlepper M, Spies HF. Effects of heart rate and atropine on ‘dual AV conduction’. Br Heart J. 1975;37:1216–27.
Wu D, Denes P, Bauernfeind R, Dhingra RC, Wyndham C, Rosen KM. Effects of atropine on induction and maintenance of atrioventricular nodal reentrant tachycardia. Circulation. 1979;59:779–88.
Lin JL, Stephen Huang SK, Lai LP, Ko WC, Tseng YZ, Lien WP. Clinical and electrophysiologic characteristics and long-term efficacy of slow-pathway catheter ablation in patients with spontaneous node pathways without inducible tachycardia. J Am Coll Cardiol. 1998;31:855–60.
Stellbrink C, Diem B, Schauerte P, Brehmer K, Schuett H, Hanrath P. Differential effects of atropine and isoproterenol on inducibility of atrioventricular nodal reentrant tachycardia. J Interv Card Electrophysiol. 2001;5:463–9.
Ito M. The effects of atropine on atrio-ventricular conduction in patients with Wolff-Parkinson-White syndrome. Studies with His bundle electrogram. Jpn Circ J. 1976;40:1285–300.
Rivarola EW, Hachul D, Wu T, Pisani C, Hardy C, Raimundi F, et al. Targets and end points in cardiac autonomic denervation procedures. Circ Arrhythm Electrophysiol. 2017;10:1–9.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Siliste, C., Siliste, RN. (2019). How to Induce Arrhythmias with Atropine. In: Cismaru, G. (eds) Arrhythmia Induction in the EP Lab. Springer, Cham. https://doi.org/10.1007/978-3-319-92729-9_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-92729-9_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-92728-2
Online ISBN: 978-3-319-92729-9
eBook Packages: MedicineMedicine (R0)